← FDA Drug Approvals (Drugs@FDA)

ALLI

NDA · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2007-02-07

Drug application

FDA Application #
NDA021887
Application type
New Drug Application
Brand name
ALLI
Generic name
ORLISTAT
Active ingredients
ORLISTAT
Dosage form
CAPSULE
Route
ORAL
Marketing status
Over-the-counter
Sponsor
HALEON US HOLDINGS
Manufacturer
Haleon US Holdings LLC
First approval
2007-02-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown